News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Bruntwood SciTech is announcing the launch of its new Life Science Accelerator programme at Alderley Park in a move aimed at supporting even greater innovation and economic growth in the reg...

Alderley Park

Aug 18th 2023

I feel very privileged and excited to be a resident at such a prestigious Science Park Alderley Park. My most recent meetings there with some of the most innovative and cutting edge #Biotech...

We’re excited to announce that Peak Proteins are now part of Sygnature Discovery; a world-leading integrated discovery and preclinical solutions provider.

Alderley Park, Cheshire Infex Therapeutics has today announced a deal with Alderley Analytical, to support PK and ADA analysis of Infex’s RESP-X program.

Dr Raquel Faba Rodríguez, Protein Purification Specialist at Peak Proteins with be joining Cytiva and Alderley Park at this online event.

Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is further strengthening its oncology and immuno-oncology capabilities with the acquis...

Peak Proteins main priorities are always the health and well-being of our staff and their families. We are working hard to continue to deliver our services within government guidelines.

Last week the Government announced the establishment of large scale national COVID-19 hub laboratories across the UK. The initial laboratories have been established in Cheshire, Milton Keyne...

Medicines Discovery Catapult integrates Alderley Park’s imaging services and expertise, further enhancing preclinical imaging capabilities

Health experts, academics and business leaders tackling the global threat of drug-resistant bacteria are gathering for the BioInfect Conference on November 8.

Investment in digital healthcare company Rinicare is a milestone deal for the Fund.

Download this Special Report, written by Mike Ward, Head of Content for Informa Pharma Intelligence Insights Portfolio, to learn how attrition rates in oncology drug discovery and developmen...

Our Valued Sponsors & Partners